Views & Analysis It’s been a long time coming for long-term topical psoriasis... Psoriasis is a tricky disease to manage, as drawbacks and side effects loom with each and every type of treatment.
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
